Patent details

EP2578229 Title: Decreasing potential iatrogenic risks associated with vaccine antigens.

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP2578229
WO Application Number:
Type:
European Patent Granted for NL
Status:
Revoked
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP12193096.0
WO Publication Number:
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
Germany (DE)
Publications:

Dates

Filing date:
09/09/2005
Grant date:
10/07/2013
EP Publication Date:
10/07/2013
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
10/07/2013
EP B1 Publication Date:
10/07/2013
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
09/09/2013
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
08/09/2025
Lapsed By Expiration Date:
Revocation Date:
26/10/2020
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
10/09/2015
 
 

 

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056 BASEL, Switzerland (CH)

Historical Applicant/holder

From:
10/07/2013
To:
10/09/2015

 

Name:
Novartis Vaccines and Diagnostics GmbH
Address:
Emil-von-Behring-Strasse 76, 35041 MARBURG, Germany (DE)

Inventor

Name:
Gregersen, Jens Peter
Address:
35041 MARBURG, Germany (DE)

Priority

Priority Patent Number:
04255471
Priority Date:
09/09/2004
Priority Country:
European Patent Office (EPO) (EP)

Classification

Main IPC Class:
A61K 39/145;
IPC or IDT classification:
C12Q 1/70;

Publication

Bulletin

1

Bulletin Heading:
VRV
Journal edition number:
52/20
Publication date:
23/12/2020
Description:
Lapse or annulment

2

Bulletin Heading:
CO
Journal edition number:
02/16
Publication date:
13/01/2016
Description:
Changes in the Netherlands Patent Register

3

Bulletin Heading:
VB1
Journal edition number:
2014/22
Publication date:
28/05/2014
Description:
Requests for restoration and notices of objection, notices of objection to Court, notices of objection to appelate court ex NL Patent Law 1995. Opposition(s) filed ex European Patent Convention

4

Bulletin Heading:
VB1
Journal edition number:
2014/21
Publication date:
21/05/2014
Description:
Requests for restoration and notices of objection, notices of objection to Court, notices of objection to appelate court ex NL Patent Law 1995. Opposition(s) filed ex European Patent Convention

5

Bulletin Heading:
EP3
Journal edition number:
2013/41
Publication date:
09/10/2013
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

6

Bulletin Heading:
EP2
Journal edition number:
2013/29
Publication date:
17/07/2013
Description:
European patents granted for the Netherlands

European Patent Bulletin

1

Issue number:
202052
Publication date:
23/12/2020
Description:
Revocation of the European patent

2

Issue number:
201421
Publication date:
21/05/2014
Description:
Opposition procedure started

3

Issue number:
201420
Publication date:
14/05/2014
Description:
Opposition procedure started

4

Issue number:
201328
Publication date:
10/07/2013
Description:
Grant (B1)

Deed

Change of owner(s)

Change Kind/ Decision Type:
Assignment
Deed Number:
RC201525064A
Date Registered:
10/09/2015
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. F.A. Geurts c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056 BASEL, Switzerland (CH)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Annual Fee

Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
15/09/2020
Last Annual Fee Paid Number:
16
Last Annual Fee Paid Amount:
1000 Euro
Payer:
Computer Patent Annuities Limited (CPA)
Filing date Document type Document Description Number of pages File Type
10/09/2015 Request for Change First filed deed 12 PDF /6/9/0/3/9/0512193096/docs/ep12193096.0_2_rfc20160111102217608.pdf
03/10/2013 Outgoing Correspondence Outgoing Letter 1 PDF /6/9/0/3/9/0512193096/docs/ep12193096.0_3_outgoingcorrespondence20131003.pdf
09/09/2013 Incoming Correspondence Paper Other 1 PDF /6/9/0/3/9/0512193096/docs/ep12193096.0_0_incomingcorrespondencepaper20130909.pdf
09/09/2013 Claims Translated claims 2 PDF /6/9/0/3/9/0512193096/docs/ep12193096.0_1_claims20130909.pdf